TCM
KDNY

Tekla Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Tekla Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		$5.8M Buy
150,863
+67,363
+81% +$2.59M 0.23% 81
2023
Q1 		$1.93M Buy
+83,500
New +$1.93M 0.07% 121